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sector must be addressed. In Sierra Leone, a speciﬁc anti-
malarial importation policy could allow for uniformity and
improve adherence to nationally recommended standards.
doi:10.1016/j.ijid.2010.02.1739114 14
elated events assists the FDA in assessing the scope of this
isk and developing appropriate public health control mea-
ures.
Disclaimer: The ﬁndings and conclusions in this abstract
ave not been formally disseminated by the Food and Drug
dministration and should not be construed to represent any
gency determination or policy.
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9.015
linical and epidemiological study of patients withmalaria
reated at the hospital central de Las Fuerzas Armadas in
ominican Republic
. Rodriguez-Taveras, L.C. Socias, C. Blanco, J.R. Reyes ∗,
.M. Puello
Hospital Central de Las Fuerzas Armadas, Santo Domingo,
ominican Republic
Background: As a tropical country, Dominican Republic
s a malaria endemic area and although it has reduced its
ncidence, continues to be in the differential diagnosis of
ebrile illnesses.
Methods: This is a retrospective study to assess the
pidemiological and clinical characteristics of patients diag-
osed with Malaria admitted from January 2008 to November
009, at the hospital, a tertiary-care center, and regional
eference, that serves to the military population, relatives
f these and the civilian population as social action. Inclu-
ion criteria were suspected diagnosis of Malaria at the time
f admission and conﬁrmed by the presence of asexual forms
n thin blood smears or thick made at the time of initial
valuation.
Results: Of 93 febrile patients admitted with suspected
alaria, this diagnosis was conﬁrmed in 13 (13.9%), 11
84.6%) were men. The mean age found was 32 Years (range
5-62). While 46.1% were found within Santo Domingo and
istrito Nacional, the distribution by region was: South
7.7%), North (7.7%), the border region (38.5%). All were
ymptomatic at diagnosis. The typical clinical presentation
bserved in most cases: fever (98.4%), headache (85.6%),
hills (46.6%), myalgia (34.5%) and jaundice (10.9%). All
ere managed within the hospital, required standard of
his military institution. All cases were autochthonous and
. falciparum were the only parasite found in all the
atients, responding satisfactory to chloroquine and pri-
aquine treatment. Death occurred in 1 (7.7%). The average
ime between the start of clinical setting and the diagnosis
as 6.5 days for patients who were transfer from other parts
f the country and 2.8 days (p < 0.05) for those who came
eeking medical care directly in the hospital.
Conclusion: Attention should be given to febrile patients,
nd test to investigate malaria must be included as a rou-
ine, regardless of the provenance, but especially those
iving in the border region with Haiti, the interval between
he clinical setting and the diagnosis has a prognosis value.
he P. falciparum is the unique species prevalent in Domini-
an Republic, and chloroquine and primaquine continues to
e therapeutic option of choice.
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rtemisinin combination therapies: Public and private
arket and policy surveys in Burundi and Sierra Leone
. Amuasi 1,∗, Y. Karikari 1, I. Boakye1, S. Blay1, L.
sabiyumva2, A. Jambai3, G. Diap4
Komfo Anokye Teaching Hospital, KUMASI, Ghana
National Malaria Control Program, BUJUMBURA, Burundi
Ministry of Health, FREETOWN, Sierra leone
Drugs for Neglected Diseases Initiative, Geneva, Switzer-
and
Background: Access to Artemisinin-based Combination
herapies (ACTs) is still limited in Africa, even though ACTs
re recommended by the WHO since 2002. In order to bet-
er understand the situation where access has traditionally
een limited, policy analyses and market surveys on anti-
alarial availability and accessibility have been conducted
n selected countries where the ACT, artesunate and amodi-
quine (AS + AQ), has been adopted as ﬁrst line.
Methods: The analyses described here were conducted
n the public and private sectors of Burundi and Sierra
eone using internationally standardized methodologies.
ata were obtained by reviewing publications; interviewing
elevant health stakeholders; and visiting hospitals, health
entres, pharmacies, and drug sale outlets.
Results: Patients are not accessing ACTs due to systemic
arriers varying between countries. In Burundi, quinine was
he most common over-the-counter antimalarial found in all
ectors despite not being ﬁrst line and being more expensive
han ACTs. Chloroquine (CQ), which has been banned from
mportation, was not found. Public sector cost of AS + AQ
0.16 USD) was found to be 1/5 the cost in the private sector
p = 0.00021). In Sierra Leone, no antimalarial importation
olicy exists, the average cost of AS + AQ was approximately
hree times the cost of CQ. Although antimalarials like
S + AQ are not expected to be sold in the public sector,
S + AQ was found in three public sector outlets at a higher
ost (1.88 USD) than either the mission/NGO cost or the
rivate-sector cost (p < 0.0001).
Conclusion: Having on-the-ground data best informs the
alaria community - including the partnership who made
he ﬁxed-dose AS/AQ available in 2007 - on how to overcome
ccess barriers to the widespread adoption and proper use of
CTs. In Burundi, the paucity and cost of ACTs in the private
